Clinical TrialsSearch results
Number of results: 2567
Other
- A PHASE 3, MULTICENTER, MULTINATIONAL, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY OF CC-93538 IN ADULT AND ADOLESCENT SUBJECTS WITH EOSINOPHILIC ESOPHAGITIS
- eosinophilic esophagitis
- Inoue Tomoyoshi
- 2022-01-22
Other
- A Phase 3, Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Induction and Maintenance Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Subjects with Eosinophilic Esophagitis
- Eosinophilic esophagitis
- Inoue Tomoyoshi
- 2021-02-19
Other
- A Phase 3, Randomized, Double-Blind, Active-Controlled, Confirmatory Study to Compare the Immunogenicity, Efficacy, and Safety of KD-414 Vaccine and Vaxzevria Vaccine in Adults Aged 18 to 40 Years Old (COVID-19)
- Prevention of COVID-19 infection
- Fushimi Hideki
- 2022-03-18
Other
- A Phase I Dose Intensification Study of three dimentional conformal thoracic radiotherapy with concurrent cisplatin and TS-1 for unresectable stage III non-small cell lung cancer
- non-small cell lung cancer
- Shizuoka Cancer Center, The Cancer Institute Hospital of JFCR
- 2008-12-02
Other
- A Phase I study of cabozantinib monotherapy in pediatric patients with recurrent and/or refractory solid tumors
- Refractory pediatric solid tumor
- Arakawa Ayumu
- 2022-02-15
Other
- A phase I study of cancer vaccine with NY-ESO-1 overlapping peptides in patients with advanced cancers expressing NY-ESO-1 antigen
- advanced esophageal cancer, stomach cancer, non-small cell lung cancer (NSCLC), malignant melanoma, bladder cancer.
- Department of Immunology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- 2009-04-10
Other
- A PHASE I STUDY OF PRALSETINIB IN PATIENTS WITH RET ALTERED SOLID TUMOR
- RET altered solid tumor
- Yanagitani Noriko
- 2021-06-11
Other
- A Phase I Study of Runimotamab
- HER2-expressing cancer (Currently breast cancer and gastric/GEJ cancer only)
- Iris Chan
- 2021-02-05
Other
- A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil; OK-432 and Montanide; ISA-51 in patients with cancers expressing NY-ESO-1 antigen
- advanced esophageal cancer, stomach cancer, non-small cell lung cancer (NSCLC), malignant melanoma
- Department of Immunology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- 2008-07-24
Other
- A phase I study of vinorelbine concurrent with thoracic radiotherapy in elderly patients with l locally advanced non-small cell lung cancer(WJTOG 3005).
- Non-small cell lung cancer
- West Japan Oncology Group
- 2008-09-26